Stryker (SYK) Stock Forecast & Price Target

$369.56

+9.83 (+2.73%)

(As of 10/18/2024 ET)

Stryker - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
4

Buy
15

Based on 19 Wall Street analysts who have issued ratings for Stryker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, and 15 have given a buy rating for SYK.

Consensus Price Target

$381.16
3.14% Upside

According to the 19 analysts' twelve-month price targets for Stryker, the average price target is $381.16. The highest price target for SYK is $406.00, while the lowest price target for SYK is $350.00. The average price target represents a forecasted upside of 3.14% from the current price of $369.56.

SYK Analyst Ratings Over Time

Type	Current Forecast 10/21/23 to 10/20/24	1 Month Ago 9/21/23 to 9/20/24	3 Months Ago 7/23/23 to 7/22/24	1 Year Ago 10/21/22 to 10/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	15 Buy rating(s)	12 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$381.16	$378.58	$372.05	$311.30
Forecasted Upside	3.14% Upside	3.77% Upside	8.59% Upside	17.17% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad)

Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.

Click here to get your FREE report delivered instantly!

SYK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SYK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Stryker Stock vs. The Competition

Type	Stryker	Medical Companies	S&P 500
Consensus Rating Score	2.79	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	3.14% Upside	13,587.63% Upside	6.19% Upside
News Sentiment Rating	Neutral News See Recent SYK News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/14/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$374.00 ➝ $383.00	+6.60%
10/14/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$345.00 ➝ $370.00	+3.89%
10/1/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$365.00 ➝ $380.00	+6.27%
9/10/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$380.00 ➝ $380.00	+4.02%
9/10/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Polark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$405.00	+11.64%
8/1/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$374.00 ➝ $402.00	+21.44%
Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad) Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth. Click here to get your FREE report delivered instantly!
8/1/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$392.00 ➝ $393.00	+20.02%
7/31/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$375.00 ➝ $365.00	+11.86%
7/31/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$386.00 ➝ $386.00	+18.25%
7/31/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$351.00 ➝ $366.00	+12.12%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$345.00 ➝ $350.00	+5.94%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$372.00	+9.06%
5/1/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$364.00 ➝ $381.00	+16.55%
5/1/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$348.00 ➝ $405.00	+24.47%
5/1/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$367.00 ➝ $378.00	+12.39%
4/11/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$365.00 ➝ $400.00	+15.82%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$362.00 ➝ $406.00	+15.19%
1/31/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$360.00	+6.66%
9/5/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$310.00 ➝ $315.00	+10.74%
5/25/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$285.00 ➝ $310.00	+13.74%
5/2/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$260.00 ➝ $292.00	-0.78%
5/2/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$285.00 ➝ $315.00	+5.04%
5/2/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$320.00 ➝ $345.00	+15.04%
4/23/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$275.00 ➝ $336.00	+10.69%
4/17/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$290.00 ➝ $312.00	+6.94%
1/25/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sector Weight ➝ Sector Weight
12/14/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$233.00 ➝ $283.00	+11.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:50 AM ET.

Should I Buy Stryker Stock? SYK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 14, 2024. Please send any questions or comments about these Stryker pros and cons to contact@marketbeat.com.

Stryker
Bull Case

Here are some ways that investors could benefit from investing in Stryker Co.:

Stryker Co. has shown consistent growth in revenue and profitability over the past few quarters, indicating a strong financial performance.
The company's innovative product pipeline, including the latest advancements in MedSurg and Neurotechnology, positions it well for future market expansion and revenue growth.
Recent insider transactions, such as the sale of shares at a higher price than the current market value, suggest confidence in the company's future prospects.
Analysts have set a positive outlook on Stryker Co., with a consensus target price above the current stock price, indicating potential for stock price appreciation.
Stryker Co.'s strong market position, diversified product portfolio, and global presence provide stability and resilience in uncertain market conditions.

Stryker
Bear Case

Investors should be bearish about investing in Stryker Co. for these reasons:

Market volatility and economic uncertainties could impact Stryker Co.'s stock price, leading to short-term fluctuations and potential investor concerns.
Increased competition in the medical technology sector may put pressure on Stryker Co.'s market share and margins, affecting its long-term growth prospects.
Regulatory changes or challenges in obtaining approvals for new products could delay product launches and impact revenue generation for Stryker Co.
The current stock price of Stryker Co. is near its 52-week high, potentially limiting immediate upside for investors looking for short-term gains.
Institutional outflows or changes in ownership by major investors could signal underlying concerns about the company's future performance and growth trajectory.

SYK Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Stryker is $381.16, with a high forecast of $406.00 and a low forecast of $350.00.
: 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SYK shares.
: According to analysts, Stryker's stock has a predicted upside of 3.14% based on their 12-month stock forecasts.
: Stryker has been rated by research analysts at Barclays, BTIG Research, Evercore ISI, Needham & Company LLC, Piper Sandler, Royal Bank of Canada, Stifel Nicolaus, Truist Financial, UBS Group, and Wolfe Research in the past 90 days.
: Analysts like Stryker more than other "medical" companies. The consensus rating score for Stryker is 2.79 while the average consensus rating score for "medical" companies is 2.79. Learn more on how SYK compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad)

Click here to get your FREE report delivered instantly!

This page (NYSE:SYK) was last updated on 10/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Stryker (SYK) Stock Forecast & Price Target